TRIMTECH Therapeutics raises $44.1M Seed (United Kingdom, Jun 2026)
$44.1M
€41 millionGenerated social card
Headline
Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work - EU-Startups
About
TRIMTECH Therapeutics is focused on developing innovative treatments for neurodegenerative diseases. The company aims to address significant unmet medical needs in this area, making it a notable player in the health sector. The recent funding round will support their research and development efforts.
Article summary
Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work EU-Startups
Investors
Related rounds
| Aug 12, 2026 | Cytix | $6.4M | Series A | United Kingdom |
| Aug 12, 2026 | Pyra | $200.0M | — | United Kingdom |
| Aug 10, 2026 | — | — | United Kingdom | |
| Aug 10, 2026 | Cambridge Aerospace | $300.0M | — | United Kingdom |